Cango: A Rebound May Not Be So Far Away (NYSE:CANG)

The TheraPharm technology has potentially broad application in the diagnosis and treatment of haematologic diseases such as blood cancers, infection management and a variety of immunodeficiency diseases. TheraPharm already has a diagnostic imaging product approved in Europe and marketed as Scintimun targeting white blood cells, for the purpose of locating areas of infection in patients…

In March last year, a Taiwanese analyst shared satellite imagery of a mysterious Chinese military facility in Inner Mongolia — deep within China’s remote deserts. A network of seemingly aimless roads winds through the site, but upon closer inspection, it mirrors the exact layout of central Taipei. That includes crude replicas of the presidential palace,…

Online luxury goods retailer Cettire has seen its shares plummet by 50% today as investors react to a profit warning. Is this a buying opportunity or a sign of trouble ahead? Shares in online luxury goods retailer Cettire [ASX:CTT] are in freefall today after the company issued a profit warning due to challenging market conditions….

Some stuff I am reading today morning: Adani buys Penna Cement ( FE ) GT Council meeting to decide rate rationalisation ( BT ) Tesla shareholders approve Elon Musk’s $56 Billion pay ( HT ) Company : United Spirits ( Rediff ) Thread : DDev Plastiks ( Caprize ) Climate Change is a huge risk…

  The Fed is set to announce its next rate cut decision, and traders everywhere are eager to see how the market will react. Whether it’s 25 or 50 basis points, the impact on the stock market could be significant. In this blog post, we explore what traders should watch for, key levels on major…